LifeSeal™ Pilot Study in Subjects Undergoing Circular Stapled Anastomosis Created Within 10 cm of the Anal Verge
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Aalst, Belgium
- OLV Ziekenhuis
-
Genk, Belgium
- Ziekenhuis Oost-Limburg
-
Gent, Belgium
- University Hospital
-
Leuven, Belgium
- UZ Leuven
-
-
-
-
-
Tel Aviv, Israel
- Sourasky Medical Center
-
-
-
-
-
Malmo, Sweden
- Skane University Hospital
-
Stockholm, Sweden
- Karolinska Institutet
-
Uppsala, Sweden, SE-751 85
- Uppsala University Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Subject, or authorized representative, signed a written Informed Consent Form
- Subject is 18 years or older
- Subject is scheduled for elective open or laparoscopic surgery involving the creation of a circular stapled anastomosis created within 10cm from the anal verge.
- If female - not be of child bearing potential, or be using acceptable contraception methods.
- Subject participating in studies involving approved drug or device will be enrolled only following a mutual consideration of the investigator together with the Sponsor.
Exclusion Criteria:
- Subject has a history of hypersensitivity to porcine derived gelatin or collagen
- Subject participating in any other study involving an investigational (unapproved) drug or device.
- Subject with a BMI higher than 40
- Female Subject states that she is pregnant or breast feeding
- Subject with ASA status higher than 3
- Avastin use within 30 days prior to surgery
- Subject who underwent a prior pelvic anastomosis
- Subject is scheduled for another surgery during the follow up period of this study (not including stoma closure)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
No Intervention: Control arm - Standard of Care
The anastomosis will be created using Standard of Care only
|
|
|
Experimental: Device arm - Standard of Care + LifeSeal™ Kit
The anastomosis will be created using SOC + LifeSeal™ Kit
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Assessment of the overall Subject safety by incidence of pre specified procedure related Adverse Events.
Time Frame: Up to 15 weeks
|
Up to 15 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Performance Rate of anastomotic leak (both radiological and clinical leaks)
Time Frame: Up to 15 weeks post procedure or at stoma closure, whichever comes first
|
Up to 15 weeks post procedure or at stoma closure, whichever comes first
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- CLP-LS-0110
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.